Involvement of the serotoninergic system in the anxiolytic action mechanism of a liposomal formulation containing nimodipine (NMD-Lipo)

This publication has 48 references indexed in Scilit:

• Evaluation of Anxiolytic effect of Erythrina mysorensis Gamb. in mice
  Indian Journal of Pharmacology, 2012
• Calcium Channel Blockers
  The Journal of Clinical Hypertension, 2011
• 5-HT1A receptor blockade reverses GABAA receptor α3 subunit-mediated anxiolytic effects on stress-induced hyperthermia
  Psychopharmacology, 2010
• Development and pharmacokinetics of nimodipine-loaded liposomes
  Journal of Pharmacy and Pharmacology, 2006
• A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety
  Pharmacology Biochemistry and Behavior, 1996
• Effects of nimodipine and other calcium channel antagonists in alcohol-preferring AA rats
  Alcohol, 1996
• Nimodipine Pharmacotherapeutic Adjuvant Therapy for Inpatient Treatment of Cocaine Dependence
  Clinical Neuropharmacology, 1994
• Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice
  Neuropharmacology, 1989
• Exploratory behavior models of anxiety in mice
  Neuroscience & Biobehavioral Reviews, 1985
• Calcium antagonist binding sites in the rat brain: Quantitative autoradiographic mapping using the 1,4-dihydropyridines [3H]PN 200-110 and [3H]PY 108-068
  Journal of Neural Transmission, 1984